Ledger.Open graph →
SEC Form D · filed May 26, 2020

Elucida Oncology, Inc

Offering
$30.0M
Sold
$7.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Monmouth Junction, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Geno Germano · Monmouth Junction, NJExec · DirectorTim Boris · Monmouth Junction, NJDirectorUlrich Wiesner · Monmouth Junction, NJDirectorTeresa Ressel · Monmouth Junction, NJDirectorMichael Smith · Monmouth Junction, NJDirectorRobert Essner · Monmouth Junction, NJExec · DirectorRobert Ruffolo · Monmouth Junction, NJDirectorJan F. Van Eck · New York, NYDirectorJohn M. Courtright · Elmhurst, ILDirectorRalph Yarro · Orem, UTDirectorAyman M. Shahin · Dubai, C0DirectorMichael Wolfgramm · Orem, UTExec · DirectorJonathan R. Simon · New York, NYDirectorSpencer Patterson · Orem, UTExec · DirectorDavid Anthony · Broomfield, CODirectorJanice Craig · Vancouver, British Columbia, CanadaDirectorDion F. Chu · New York, NYExec · DirectorMichael F. Peng · New York, NYDirectorHelene Servillon · Dover, DEExec · DirectorKara Forney · Albuquerque, NMDirectorDane F. Lund · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗